re.Mind Capital is a venture capital investment firm established in 2020 and based in Sliema, Malta. It operates as the mental health investment division of entrepreneur Christian Angermayer and his family office, Apeiron Investment Group. The firm focuses on investing in companies that offer innovative solutions to address global mental health challenges, with a particular emphasis on the neuroscience and life sciences sectors. Through its investments, re.Mind Capital aims to contribute to the advancement of mental health care and support the development of technologies and services that improve mental well-being.
Motif Neurotech is a company focused on developing minimally invasive bioelectronic implants aimed at monitoring and treating severe mental illnesses, particularly treatment-resistant depression. Through its innovative approach, the company specializes in wireless power and data transmission, which facilitates the creation of new, miniature implants designed for tissue stimulation and diagnostic readings. This technology enables patients to potentially repair neural circuits using minimally invasive electronic therapies, offering hope for more effective treatment options for those struggling with mental health challenges.
Alena
Seed Round in 2022
Alena is a healthcare application developer that utilizes neuroscience-based games to evaluate user behavior and identify thinking patterns linked to mental health disorders. Founded in 2019 in London, the company combines insights from computational neuroscience and psychiatry to enhance user understanding and treatment options. Its application offers a unique approach that merges evidence-based therapy with innovative techniques to address social anxiety and other mental health challenges. By dynamically adapting to users' evolving needs, Alena aims to facilitate effective stress management and help users overcome anxiety, thereby improving overall mental well-being.
Delix Therapeutics
Series A in 2021
Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel neuroplasticity-promoting therapeutics—to better treat mental health disorders at scale. The company was founded in 2019 and is headquartered in Boston, Massachusetts.
Tripp
Series A in 2021
Tripp Inc. is a company focused on developing a digital psychedelic wellness platform that utilizes virtual and augmented reality to enhance emotional well-being. Founded in 2016 and headquartered in Los Angeles, California, with a satellite office in Chicago, the company creates immersive experiences that combine audio, visual elements, and gameplay mechanics to promote mindfulness and transformation. Tripp’s offerings are informed by scientific research indicating that interactive digital experiences can positively influence brain function. Through its platform, the company delivers wellness solutions designed to help users manage their emotions, reduce stress and anxiety, and achieve a state of calm and focus.
Ksana Health
Seed Round in 2021
Ksana Health, founded in 2019 and based in Eugene, Oregon, is a developer of a digital mental health platform that aims to enhance mental health outcomes through personalized behavioral insights and timely interventions. The company's platform enables the collection of mental health data from users, which is then seamlessly transferred to healthcare practitioners via an app. By providing passive and continuous remote patient monitoring alongside digital therapeutics, Ksana Health seeks to support individuals in managing their mental health effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.